Document Detail

Intravenous nitroglycerin in acute myocardial infarction.
MedLine Citation:
PMID:  6407314     Owner:  NLM     Status:  MEDLINE    
Until recently, the use of nitroglycerin in patients with acute myocardial infarction has been contraindicated primarily because of possible hypotension or tachycardia which, with sublingual or oral preparations, would be difficult to control. The introduction of intravenous nitroglycerin and its use during experimentally induced infarction paved the way for its use in patients with acute myocardial ischemia. It was shown that nitroglycerin, administered intravenously during experimentally induced coronary artery occlusion, redistributed flow to the subendocardium of the ischemic area while it maintained flow to the normal areas and was associated with decreased S-T segment elevation. Preliminary studies in patients with acute infarction have confirmed the beneficial effect of intravenous nitroglycerin on S-T segment elevation, and a subsequent study in 31 patients with acute infarction showed a decrease in infarct size with improved hemodynamics. In a more recent randomized prospective study in 85 patients with acute myocardial infarction, we found that intravenous nitroglycerin was associated with a decrease in infarct size in patients with inferior infarction (36 percent reduction, p less than 0.05) but that it had no effect on infarct size in patients with anterior infarction. Whether or not nitroglycerin should be used routinely for reduction of infarct size remains to be determined, but results indicate that it is effective and safe for the treatment of cardiac failure in patients with acute myocardial infarction.
R Roberts
Related Documents :
21376834 - Differentiating pacemaker-mediated tachycardia from tachycardia due to atrial tracking:...
9781974 - Coronary thrombosis during acute myocardial infarction: roberts was right!
15546824 - The 1999 ji-ji (taiwan) earthquake as a trigger for acute myocardial infarction.
21587214 - Diagnostic and prognostic value of 3d noga mapping in ischemic heart disease.
3184454 - Serial analysis of spontaneous and induced ventricular arrhythmias in a canine model of...
2366314 - Evaluation of left-sided valvular regurgitation in healthy, hypertensive and myocardial...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  The American journal of medicine     Volume:  74     ISSN:  0002-9343     ISO Abbreviation:  Am. J. Med.     Publication Date:  1983 Jun 
Date Detail:
Created Date:  1983-07-29     Completed Date:  1983-07-29     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0267200     Medline TA:  Am J Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  45-52     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Pressure / drug effects
Coronary Circulation / drug effects
Heart Rate / drug effects
Infusions, Parenteral
Middle Aged
Myocardial Infarction / drug therapy*,  pathology
Nitroglycerin / administration & dosage*,  pharmacology
Prospective Studies
Random Allocation
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect of glyceryl trinitrate on coronary and systemic hemodynamics in man.
Next Document:  Comparison of intravenous nitroglycerin and sodium nitroprusside in acute myocardial infarction.